Lululemon Shares Dropped After the Company Cut Its Annual Forecast. Is the Stock a Buy Amid the Selloff?

Lululemon reported fiscal Q1 revenue of $2.47 billion, but net income fell 38% to $195 million and EPS dropped to $1.69 from $2.60 a year ago. Management cut full-year guidance to $11.0 billion-$11.15 billion in revenue and $10.95-$11.15 in EPS, citing weak U.S. sales, product missteps, and negative brand commentary. The stock is down 43% this year, with multiple analyst target cuts following the earnings and outlook disappointment.

Analysis

The market is likely discounting this as a simple brand stumble, but the deeper issue is channel productivity: when a premium retailer loses traffic, the fixed-cost deleverage shows up fast, and that is exactly what the margin compression is signaling. The U.S. decline matters more than the China growth because domestic weakness usually leads wholesale/marketing inefficiency, heavier markdown risk, and a longer repair cycle than a geography mix-shift can offset.

The leadership reset is a double-edged catalyst. Settling the proxy fight removes an overhang, but it also reveals how much brand governance had become a drag on decision velocity; the next 2-3 quarters are likely to be spent on merchandising cleanup and message discipline rather than accelerating top-line growth. That suggests estimates are still too high if management needs multiple seasons to re-establish product relevance and traffic.

A key second-order risk is that premium athletic apparel has limited pricing elasticity in a slowdown: if they defend ASPs, units keep slipping; if they discount, margin mix deteriorates further. The cleanest way for the stock to stabilize would be evidence of U.S. comp inflection and lower negative social sentiment before the new CEO arrives, but the setup implies those are months-away rather than immediate catalysts. In the meantime, every analyst target cut tends to matter more because the stock is being de-rated on both growth and quality of earnings.

Contrarianly, the selloff may be partially overdone if China growth persists and the company can harvest some tariff relief, but that upside is more about protecting the floor than restoring the old multiple. The right framing is not whether the business is broken, but whether it deserves a premium valuation while domestic comps are negative and leadership is still interim. On balance, the risk/reward still favors patience over catching the falling knife.

Key Decisions for Investors

• Stay short / avoid LULU for the next 1-2 quarters; the setup favors multiple compression if U.S. traffic and comps do not inflect before Heidi O’Neill starts.
• For hedged longs, pair short LULU vs long NKE over 3-6 months: NKE has lower brand controversy risk and more room to leverage a reset narrative if athletic wear demand normalizes.
• If expressing a tactical downside view, buy LULU put spreads 1-2 earnings cycles out; the thesis is not bankruptcy, but a slower-than-expected margin recovery with limited near-term catalyst risk.
• Only consider re-adding LULU on evidence of U.S. comp stabilization and reduced negative commentary; absent that, the stock is likely to remain range-bound to lower despite China strength.